Certara to Open New Office in China

In the Lab eNewsletter, Pharmaceutical Technology's In the Lab eNewsletter 12-02-2020, Volume 15, Issue 12

The new office will provide the company with opportunities to collaborate more efficiently with customers in the Chinese biopharmaceutical industry.

Certara, a US-based biosimulation company, is opening a new office in Shanghai, China’s Pudong District, a hub for biopharmaceutical research and development.

The new office will provide the company with opportunities to collaborate more efficiently with customers in the Chinese biopharmaceutical industry, a Nov. 9, 2020 company press release said.

“We recognize the tremendous growth of China’s biopharmaceutical industry and are thrilled to have a direct presence in China so that we can fully support our rapidly growing Chinese customer base,” said William F. Feehery, PhD, CEO of Certara, in the press release. “Certara’s extensive experience in biosimulation and our partnerships with top global biopharmaceutical companies will help foster innovation in China, accelerate time-to-market for our customers, and most importantly, improve patient outcomes.”

Source: Certara